~~<i id='14F084CD3A'><strike id='14F084CD3A'><tt id='14F084CD3A'><pre id='14F084CD3A'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

fashion

author：explore 2025-09-30 00:34:52 - browse：8212

Alkermes shareholders voted Thursday to re-elect all of the drugmaker’s current directors, ending an acrimonious proxy fight with hedge fund Sarissa Capital Management, which had sought to seat three directors on the board.

At the company’s annual meeting, shareholders voted in favor of Alkermes’ proposal to retain all seven of the director nominees to the 11-person board.

The outcome is a setback for Sarissa, which owns 8.5% of Alkermes and is run by activist investor Alex Denner. Sarissa has accused Alkermes executives of mismanaging the business and destroying shareholder value.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： ChatGPT in medicine: STAT answers readers' burning questions
Next article： Readout Newsletter: Bayer study halts, Carmot to IPO, and more

Wikipedia

hotspot

knowledge

hotspot

focus

leisure time

CRISPRpioneersJenniferDoudnaandFengZhangIllustration:STAT;Photos:AP,GettyTherevolutionstartedinsilen

WSS

7 of the most gruesome medical devices in history

Readout Newsletter: What is Casgevy? Does Wegovy hurt muscle?

Buoyed by wins on obesity, Novo Nordisk eyes heart disease

White House launches permanent pandemic office

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

Gain of function research would be limited under House proposal

entertainment

fashion

Wikipedia

Walensky prepares to leave CDC — and Congress — behind

HIPAA doesn't protect reproductive records from prosecutors

Hollywood unions extend contract negotiations for actors

Gain of function research would be limited under House proposal

Novavax promises a turnaround & Lilly roils the obesity market

Vatican is moving ahead with plan to reunite Ukrainian children taken to Russia with their families

After affirmative action ruling, medical educators look to 'holistic review'

How artificial intelligence is being used to detect, treat cancer

Anesthesiologist group: stop taking Ozempic before surgery

Ransomware attacks on hospitals: Study outlines patient impact

hotspot

Review: 'Barbie' will hit you like a shot in the heart

Marvel Studios reveals new trailer for 'The Marvels': Watch here

Readout Newsletter: Bayer's future, Merck Caraway acquisition, etc

FDA official pushes for dedicated emerging pathogens team

Surge of respiratory disease in China has likely explanation

U.K. considers world's first use of meningitis vaccine to address gonorrhea

knowledge

hotspot

focus

leisure time